”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only) – Stratipath

”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only)

September 26, 2022

Read the article (Swedish only)

MORE NEWS:

Stratipath and PathAI Partner to Expand Access to AI-based Precision Diagnostics

Stratipath and Visiopharm partner to advance implementation of AI-Powered Breast Cancer Diagnostics

First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast

Region Östergötland Implements AI-Powered Stratipath Breast to Enhance Breast Cancer Diagnostics

Press releases:

Stratipath and PathAI Partner to Expand Access to AI-based Precision Diagnostics

Stratipath and Visiopharm partner to advance implementation of AI-Powered Breast Cancer Diagnostics

Region Östergötland Implements AI-Powered Stratipath Breast to Enhance Breast Cancer Diagnostics

Region Uppsala chooses to implement AI-based risk profiling with Stratipath Breast

IN THE MEDIA:

First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast

ESMO daily: AI integration in breast cancer – a long way ahead?

Stratipath team contributes to foundation model research published in Nature

Pharma Times: Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK